An Implantable Carotid Sinus Baroreflex Activating System: Surgical Technique and Short-Term Outcome from a Multi-Center Feasibility Trial for the Treatment of Resistant Hypertension

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 4, 2007, Pages 414-421

  Tordoir, J H M ^a   Scheffers, I ^a   Schmidli, J ^b   Savolainen, H ^b   Liebeskind, U ^c   Hansky, B ^d   Herold, U ^e   Irwin, E ^f   Kroon, A A ^a   de Leeuw, P ^a   Peters, T K ^g   Kieval, R ^g   Cody, R ^g  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f Department of Surgery ^*  (United States)

^g CVRX INC   (United States)

Author keywords

Autonomic nervous system; Baroreflex; Carotid sinus; Hypertension; Medical device; Surgery

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EQUIPMENT; CAROTID SINUS PRESSORECEPTOR REFLEX; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; ELECTRODE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; IMPLANT; MALE; MULTICENTER STUDY; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULSE GENERATOR; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BLOOD PRESSURE; CAROTID SINUS; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; EUROPE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33847352561     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.11.025     Document Type: Article

References (37)

1. Alderman M.H., Budner N., Cohen H., Lamport B., and Ooi W.L. Prevalence of drug resistant hypertension. Hypertension 11 Suppl. II (1988) II71-II75
2. Alper Jr. A.B., and Calhoun D.A. Contemporary management of refractory hypertension. Curr Hypertens Rep 1 (1999) 402-407
3. Calhoun D.A., Zaman M.A., and Nishizaka M.K. Resistant hypertension. Curr Hypertens Rep 4 (2002) 21-28
4. Levy E.I., Scarrow A.M., and Jannetta P.J. Microvascular decompression in the treatment of hypertension: review and update. Surg Neurol 55 1 (2001) 2-10 (discussion 10-11)
5. Ram C.V.S., and Fenves A. Refractory hypertension. Curr Concepts Hypertens 4 4 (2002) 3-6
6. Bertholet N., Favrat B., Fallab-Stubi C., Brunner H.R., and Burnier M. Why objective monitoring of compliance is important for the management of hypertension. J Clin Hypertens 2 (2000) 258-262
7. Burnier M., Schneider M.P., Chiolero A., Fallab-Stubi C.L., and Brunner H.R. Electronic compliance monitoring in resistant hypertension: the basis for rationale therapeutic decisions. J Hypertens 19 (2001) 335-341
8. Nuesch R., Schroeder K., Dieterle T., Martina B., and Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 323 (2001) 142-146
9. Cuspidi C., Macca G., Sampieri L., Michev I., Salerno M., Fusi V., et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19 (2001) 2063-2070
10. Pierdomenico S.D., Lapenna D., Bucci A., Di Tommaso R., Di Mascio R., Manente B.M., et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18 (2005) 1422-1428
11. Bilgutay A.M., and Lillehei C.W. Treatment of hypertension with an implantable electronic device. JAMA 191 (1965) 649-653
12. Agishi T., Temples J., and Peirce E.C. Electrical stimulation of the carotid sinus nerve as an experimental treatment of hypertension. J Surg Res 9 (1969) 305-309
13. Schwartz S.I., and Griffith L.S.C. Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg 114 (1967) 5-15
14. Braunwald N.S., Epstein S.E., and Braunwald E. Carotid sinus nerve stimulation for the treatment of intractable angina pectoris: surgical technic. Ann Surg 172 (1970) 810-816
15. Parsonnet V., Rothfeld E.L., Raman K.V., and Myers G.H. Electrical stimulation of the carotid sinus nerve. Surg Clin North Am 49 (1969) 589-596
16. Reich T., Tuckman J., Lyon A.F., and Jacobson II J.H. The effects of radio frequency carotid sinus nerve stimulators in severe hypertension. Surg Forum 18 (1967) 174-176
17. Brest A.N., Wiener L., and Bachrach B. Bilateral carotid sinus nerve stimulation in the treatment of hypertension. Am J Cardiol 29 (1972) 821-825
18. Sleight P. Arterial baroreflexes can determine long-term blood pressure. Baroreceptors and hypertension: time for a re-think?. Exp Physiol 89 (2004) 331-335
19. Grassi G. Counteracting the sympathetic nervous system in essential hypertension. Curr Opin Nephrol Hypertens 13 (2004) 513-519
20. Thrasher T.N. Baroreceptors, baroreceptor unloading, and the long-term control of blood pressure. Am J Physiol Regul Integr Comp Physiol 288 (2005) R819-R827
21. Lohmeier T.E., Irwin E.D., Rossing M.A., Serdar D.J., and Kieval R.S. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 43 (2004) 306-311
22. Lohmeier T.E., Dwyer T.M., Hildebradt D.A., Irwin E.D., Rossing M.A., Kieval R.S., et al. Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension 46 (2005) 1194-1200
23. Lohmeier T.E., Dwyer T.M., Irwin E.D., Rossing M., and Kieval R.S. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 46 (2005) 816
24. Schmidli J., Savolainen H., Irwin E., Peters T., Cain C., Martin R., et al. A completely new treatment for hypertension?. J Hypertens 22 Suppl. 2 (2004) S252
25. de Leeuw P.W., Kroon A.A., Scheffers I., Tordoir J., Schmidli J., Mohaupt M., et al. Baroreflex hypertension therapy with chronically implanted system: preliminary efficacy and safety results from the Rheos DEBuT-HT study in patients with resistant hypertension. J Hypertens 24 Suppl. 4 (2006) S300-S301
26. Eberle B., Schmidli J., Irwin E.D., Peters T., and Carrel T. Evaluation of an anesthetic regimen for testing electrical activation of the carotid baroreflex. Anesthesiology 103 (2005) A372
27. Gasser H.S. Recruitment of nerve fibers. Am J Physiol 121 (1937) 193-202
28. Gorman P.H., and Mortimer J.T. The effect of stimulus parameters on the recruitment characteristics of direct nerve stimulation. IEEE Trans Biomed Eng 30 (1983) 407-414
29. Seller H., and Illert M. The localization of the first synapse in the carotid sinus baroreceptor reflex pathway and its alteration of the afferent input. Pflugers Arch 306 (1969) 1-19
30. Borst C., Karemaker J.M., Dunning A.J., Bouman L.N., and Wagner J. Frequency limitation in the human baroreceptor reflex. J Auton Nerv Syst 9 (1983) 381-397
31. Black H.R., El Shahawy M., Weiss R.J., Tannoury G., Marple R., Weber M., et al. Darusentan antihypertensive effect in patients with resistant systolic hypertension. J Am Coll Cardiol 47 4 Suppl. A (2006) 299A (Abstract 915-208)
32. Bisognano J., Sloand J., Papedemetriou V., Rothstein M., Sica D., Flack J., et al. Baroreflex hypertension therapy with a chronically implanted system: early results from the Rheos feasibility trial in patients with resistant hypertension. J Clin Hypertens No 4 Suppl. A8 (2006) A43
33. Voigt A., Shalaby A., and Saba S.F. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 48 (2006) 590-591
34. Reynolds M.R., Cohen D.J., Kugelmass A.D., Brown P.P., Becker E.R., Culler S.D., et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2493-2497
35. Baddour L.M., Bettmann M.A., Bolger A.F., Epstein A.E., Ferrieri P., Gerber M.A., et al. Nonvalvular cardiovascular device-related infections. Circulation 108 (2003) 2015-2031
36. Uslan D.Z., and Baddour L.M. Cardiac device infections: getting to the heart of the matter. Nosocomial and hospital-related infections. Curr Opin Infect Dis 19 (2006) 346-348
37. Grassi G. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options. Curr Hypertens Rep 5 (2003) 277-280